Tradewinds Capital Management »

Lineage Cell Therapeutics In shares owned by Tradewinds Capital Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Tradewinds Capital Management from 13F filings

Historical chart of Tradewinds Capital Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Tradewinds Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Tradewinds Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $294 224 1.31

More positions owned by Tradewinds Capital Management

Ishares Msci Sth Kor Etf (EWY)
Select Sector Spdr Tr St Str Energ Etf (XLE)
Ishares Tr Gl Clean Ene Etf (ICLN)
J P Morgan Exchange Traded F Beta Cda Etf New (BBCA)
Ishares U S Etf Tr Gsci Cmdty Stgy (COMT)
Abrdn Silver Etf Trust Physcl Silvr Shs (SIVR)
Franklin Templeton Etf Tr Ftse Untd Kgdm (FLGB)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Spdr Index Shs Fds St Str Nat Etf (GNR)
Spdr Series Trust St Nuve High Etf (HYMB)
Ishares Tr Conv Bd Etf (ICVT)
Spdr Index Shs Fds St Port Mark Etf (SPEM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Mun Bd Fds Core Tax Exempt (VCRM)
Ishares Tr Mbs Etf (MBB)

View all positions for Tradewinds Capital Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
BlackRock
Armistice Capital
Marshall Wace
Geode Capital Management
Renaissance Technologies
Morgan Stanley
Susquehanna International
UBS Group
Vanguard Fiduciary Trust

View all funds holding Lineage Cell Therapeutics In